Matthew M Walsh is Chief Financial Officer of Organon & Co.. Currently has a direct ownership of 91,974 shares of OGN, which is worth approximately $1.35 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 3,541 shares (Common Stock) at a price of $20.35 per share, resulting in proceeds of $72,059. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K
4.13% 3M change
75.49% 12M change
Total Value Held $1.35 Million

MATTHEW M WALSH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Payment of exercise price or tax liability
$72,059 $20.35 p/Share
3,541 Reduced 3.71%
91,974 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
7,189 Added 7.0%
95,515 Common Stock
May 04 2024
SELL
Payment of exercise price or tax liability
$80,263 $19.61 p/Share
4,093 Reduced 4.43%
88,326 Common Stock
May 04 2024
BUY
Exercise of conversion of derivative security
-
8,310 Added 8.25%
92,419 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$183,337 $18.8 p/Share
9,752 Reduced 10.39%
84,109 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
19,799 Added 18.03%
90,042 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$205,529 $18.04 p/Share
11,393 Reduced 13.33%
74,062 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
33,044 Added 27.89%
85,455 Common Stock
Aug 05 2023
SELL
Payment of exercise price or tax liability
$236,959 $21.53 p/Share
11,006 Reduced 17.35%
52,411 Common Stock
Aug 05 2023
BUY
Exercise of conversion of derivative security
-
22,347 Added 26.06%
63,417 Common Stock
May 04 2023
SELL
Payment of exercise price or tax liability
$98,002 $24.24 p/Share
4,043 Reduced 8.96%
41,070 Common Stock
May 04 2023
BUY
Exercise of conversion of derivative security
-
8,310 Added 15.56%
45,113 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$61,327 $23.09 p/Share
2,656 Reduced 6.73%
36,803 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
7,753 Added 16.42%
39,459 Common Stock
Aug 05 2022
SELL
Payment of exercise price or tax liability
$349,704 $32.41 p/Share
10,790 Reduced 25.39%
31,706 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
-
22,343 Added 34.46%
42,496 Common Stock
May 04 2022
SELL
Payment of exercise price or tax liability
$92,357 $32.44 p/Share
2,847 Reduced 12.38%
20,153 Common Stock
May 04 2022
BUY
Exercise of conversion of derivative security
-
8,310 Added 26.54%
23,000 Common Stock
Aug 05 2021
SELL
Payment of exercise price or tax liability
$219,105 $28.63 p/Share
7,653 Reduced 34.25%
14,690 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$639,680 $28.63 p/Share
22,343 Added 50.0%
22,343 Common Stock

Also insider at

CERT
Certara, Inc. Healthcare
MMW

Matthew M Walsh

Chief Financial Officer
Jersey City, NJ

Track Institutional and Insider Activities on OGN

Follow Organon & Co. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

News

Receive news related to Organon & Co.

Track Activities on OGN